Tag: large hemispheric infarction

Remedy announces upcoming presentation of “groundbreaking” CHARM study data at ISC...

Remedy Pharmaceuticals has announced that three speaker presentations reporting efficacy data from both the Phase 2 GAMES-RP and Phase 3 CHARM studies on its...

Remedy announces US FDA orphan drug designation to treat large-territory acute...

Remedy Pharmaceuticals has announced that the US Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted orphan drug designation to...

Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in...

Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a...